| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 7.470 | 1.236 | 799 | 3.605 | - |
| Total Income - EUR | - | - | - | 0 | 0 | 7.646 | 1.236 | 1.018 | 3.610 | - |
| Total Expenses - EUR | - | - | - | 166 | 404 | 6.840 | 563 | 1.531 | 2.453 | - |
| Gross Profit/Loss - EUR | - | - | - | -166 | -404 | 805 | 674 | -513 | 1.157 | - |
| Net Profit/Loss - EUR | - | - | - | -166 | -404 | 589 | 637 | -543 | 893 | - |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Tehnofarma Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 119 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | - | - | 87 | 39 | 20.050 | 20.451 | 19.278 | 20.485 | - |
| Inventories | - | - | - | 0 | 0 | 14.621 | 13.818 | 17.105 | 15.605 | - |
| Receivables | - | - | - | 0 | 24 | 5.165 | 6.335 | 1.813 | 4.112 | - |
| Cash | - | - | - | 87 | 15 | 264 | 298 | 361 | 768 | - |
| Shareholders Funds | - | - | - | -123 | -525 | 73 | 709 | -737 | 33 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 329 | 564 | 19.977 | 19.742 | 20.015 | 20.452 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Tehnofarma Medical S.r.l.